Concepedia

Precision Drug Repurposing

Precision Drug Repurposing is a computational drug repurposing approach that integrates individual patient genomic, epigenomic, and clinical data to identify targeted therapeutic candidates with high specificity for defined molecular disease subtypes, thereby enabling personalized treatment strategies.

27

Publications

1.1K

Citations

129

Authors

96

Institutions

Publications per year

2017–2026

26

Parents

Publications

27

Deep learning for drug repurposing: Methods, databases, and applications

Xiaoqin Pan, Xuan Lin, Dongsheng Cao et al. · Wiley Interdisciplinary Reviews Computational Molecular Science · 2022 · 175 citations

, , +16

A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data

Ruoqi Liu, Lai Wei, Ping Zhang · Nature Machine Intelligence · 2021 · 110 citations · Full text

, , +15

Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study

Yajie Meng, Min Jin, Xianfang Tang et al. · Applied Soft Computing · 2021 · 81 citations · Full text

, , +13

Artificial intelligence, drug repurposing and peer review

Jeremy M. Levin, Tudor I. Oprea, Sagie Davidovich et al. · Nature Biotechnology · 2020 · 78 citations

, , +16

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?

Pan Pantziarka, Gauthier Bouche, Nicolás André · Frontiers in Pharmacology · 2018 · 66 citations · Full text

, , +16

1–5 of 27

Authors

129

  1. PP
    Pan Pantziarka

    Anticancer Fund, Belgium

    2 publications · 82 citations

    2

    h-index

  2. JK
    Jana K. Shirey-Rice

    Vanderbilt University, United States

    2 publications · 67 citations

    2

    h-index

  3. PS
    Philip S. Yu

    University of Illinois Chicago, United States

    2 publications · 186 citations

    2

    h-index

  4. JM
    Jill M. Pulley

    Vanderbilt University, United States

    2 publications · 67 citations

    2

    h-index

  5. RR
    Robert R. Lavieri

    Vanderbilt University Medical Center, United States

    2 publications · 67 citations

    2

    h-index

1–5 of 129

Institutions

96

  1. Vanderbilt University Medical Center

    Nashville, United States

    4 h-index

    37 publications

    1.6K citations

  2. Vanderbilt University

    Nashville, United States

    3 h-index

    19 publications

    950 citations

  3. The George Institute for Global Health

    London, United Kingdom

    2 h-index

    2 publications

    82 citations

  4. Anticancer Fund

    Grimbergen, Belgium

    2 h-index

    4 publications

    164 citations

  5. National Human Genome Research Institute

    Bethesda, United States

    2 h-index

    2 publications

    83 citations

  6. Inserm

    Paris, France

    2 h-index

    4 publications

    174 citations

  7. National Institutes of Health

    Bethesda, United States

    2 h-index

    2 publications

    83 citations

  8. Hunan University

    Changsha, China

    2 h-index

    6 publications

    674 citations

1–8 of 96

Venues

  1. Methods in molecular biology

    Book series · 3 publications · 65 citations

    3

    h-index

  2. Assay and Drug Development Technologies

    2 publications · 67 citations

    2

    h-index

  3. Applied Soft Computing

    2 publications · 95 citations

    2

    h-index

  4. Frontiers in Medicine

    2 publications · 81 citations

    2

    h-index

  5. Digital Medicine

    1 publications · 17 citations

    1

    h-index

1–5